The global market for Blood Banking and Blood Products is estimated at US$50.0 Billion in 2023 and is projected to reach US$69.0 Billion by 2030, growing at a CAGR of 4.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the blood banking and blood products market is driven by several factors, including technological advancements, increased awareness of the importance of blood donation, and rising global health care demands. Technological innovations that improve the efficiency of blood collection, processing, and storage are crucial, as they enhance the overall safety and availability of blood supplies. Demographic trends, such as aging populations and the consequent rise in medical conditions that require blood transfusions, also contribute significantly to market expansion. Additionally, initiatives aimed at increasing donor participation and retention have been vital in meeting the growing demand for blood products.
Campaigns that educate the public about the need for and benefits of donating blood, coupled with enhanced donor recruitment strategies, are essential for maintaining a stable blood supply. Furthermore, expanding healthcare infrastructure in emerging economies is increasing access to medical treatments that require blood products, thereby broadening the market. These factors, combined with ongoing research and development in transfusion medicine, continue to drive the dynamic growth of this critical sector.
The growth in the blood banking and blood products market is driven by several factors, including technological advancements, increased awareness of the importance of blood donation, and rising global health care demands. Technological innovations that improve the efficiency of blood collection, processing, and storage are crucial, as they enhance the overall safety and availability of blood supplies. Demographic trends, such as aging populations and the consequent rise in medical conditions that require blood transfusions, also contribute significantly to market expansion. Additionally, initiatives aimed at increasing donor participation and retention have been vital in meeting the growing demand for blood products.
Campaigns that educate the public about the need for and benefits of donating blood, coupled with enhanced donor recruitment strategies, are essential for maintaining a stable blood supply. Furthermore, expanding healthcare infrastructure in emerging economies is increasing access to medical treatments that require blood products, thereby broadening the market. These factors, combined with ongoing research and development in transfusion medicine, continue to drive the dynamic growth of this critical sector.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Blood Components & Plasma Products segment, which is expected to reach US$56.4 Billion by 2030 with a CAGR of a 4.9%. The Equipment, Blood Tests & Other Consumables segment is also set to grow at 3.9% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $13.2 Billion in 2023, and China, forecasted to grow at an impressive 7.4% CAGR to reach $15.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Blood Banking and Blood Products Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Blood Banking and Blood Products Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Blood Banking and Blood Products Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as AABB, Abbott Laboratories, American Red Cross, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 209 Featured):
- AABB
- Abbott Laboratories
- American Red Cross
- America's Blood Centers
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- Beijing Tiantan Biological Products Co., Ltd.
- Bharat Serums and Vaccines Ltd.
- Bio Products Laboratory Ltd.
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Biotest AG
- Canadian Blood Services
- Cerus Corporation
- China Biologic Products, Inc.
- CSL Behring LLC
- Fenwal Inc.
- Fresenius Kabi AG
- Grifols S.A.
- Haemonetics Corporation
- Immucor Inc.
- Kawasumi Laboratories, Inc.
- Kedrion S.p.A.
- LFB Group
- MacoPharma SA
- New York Blood Center
- Octapharma AG
- Ortho-Clinical Diagnostics, Inc.
- Shanghai RAAS Blood Products Co., Ltd.
- Shire plc
- Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
- Terumo BCT Inc.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AABB
- Abbott Laboratories
- American Red Cross
- America's Blood Centers
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- Beijing Tiantan Biological Products Co., Ltd.
- Bharat Serums and Vaccines Ltd.
- Bio Products Laboratory Ltd.
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Biotest AG
- Canadian Blood Services
- Cerus Corporation
- China Biologic Products, Inc.
- CSL Behring LLC
- Fenwal Inc.
- Fresenius Kabi AG
- Grifols S.A.
- Haemonetics Corporation
- Immucor Inc.
- Kawasumi Laboratories, Inc.
- Kedrion S.p.A.
- LFB Group
- MacoPharma SA
- New York Blood Center
- Octapharma AG
- Ortho-Clinical Diagnostics, Inc.
- Shanghai RAAS Blood Products Co., Ltd.
- Shire plc
- Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
- Terumo BCT Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 357 |
| Published | October 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 50 Billion |
| Forecasted Market Value ( USD | $ 69 Billion |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
